Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 41944198

Characteristics of Protein Profiling and Biomarkers in Aortic Regurgitation With Heart Failure.

Cheng-Yao Ni·Hai-Tao Hou·Hai-Ge Zhao·Yi-Ming Ni·Liang Ma·Guo-Wei He
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Valvular heart disease, particularly aortic valve disease including stenosis and regurgitation, is a common heart disease. This study aimed to explore the protein profiling and the biomarkers in severe aortic valve disease and to provide new insights into the therapeutic strategy. METHODS: Blood samples from 80 subjects were collected and analyzed by data independent acquisition technique in 3 comparisons (mild/moderate-control, severe-control, and severe-mild/moderate) and validated by ELISA. The diagnostic value of differentially expressed proteins associated with severe valvular heart disease was also evaluated by the receiver operating characteristic curve. RESULTS: A total of 9976 peptides and 451 proteins were identified through liquid chromatography-tandem mass spectrometry analysis. From these, 64 in mild/moderate-control, 50 in severe-control, and 50 in severe-mild/moderate comparisons were identified as differentially expressed proteins. IGFBP7 (insulin-like growth factor-binding protein 7; 5581.0&#xb1;697.0&#x2009;ng/mL), DSG1 (desmoglein-1; 21.0&#xb1;2.0 pg/mL), ADIPOQ (adiponectin; 26&#x2009;686.0&#xb1;3730&#x2009;ng/mL), and JUP (junction plakoglobin; 10.2&#xb1;0.6&#x2009;ng/mL) levels in the severe group were significantly higher than that in the mild/moderate (P<0.05) group. Additionally, ADIPOQ and JUP levels in the severe group were also higher than that in control (P<0.001). Receiver operating characteristic curve analysis showed that IGFBP7, DSG1, JUP, and ADIPOQ had strong potential value to be associated with severe aortic valve disease. CONCLUSIONS: By constructing proteomics profile to identify the protein characteristics this study found that increased IGFBP7, DSG1, JUP, and ADIPOQ are the characteristics of proteins in patients with severe valvular heart disease. These findings provide new insight into the diagnosis and pathogenesis of valvular heart disease, particularly aortic valve disease.

Explore related subjects

HumansBiomarkersAortic Valve InsufficiencyFemaleMaleHeart FailureProteomicsSeverity of Illness IndexTandem Mass SpectrometryAgedEnzyme-Linked Immunosorbent AssayCase-Control StudiesMiddle AgedROC CurveChromatography, LiquidAdiponectinInsulin-Like Growth Factor Binding ProteinsPredictive Value of TestsADIPOQIGFBP7aortic regurgitationdata independent acquisitionproteomicsJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cheng-Yao Ni, Hai-Tao Hou, Hai-Ge Zhao, Yi-Ming Ni, Liang Ma, Guo-Wei He. 2026-04-07. Characteristics of Protein Profiling and Biomarkers in Aortic Regurgitation With Heart Failure.. https://doi.org/10.1161/jaha.125.047122

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗